ILLUMINA INC (ILU.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:ILU - US4523271090 - Common Stock
ILU.DE Key Statistics, Chart & Performance
The current stock price of ILU.DE is 114.38 EUR. In the past month the price increased by 2.4%. In the past year, price decreased by -9.85%.
ILU.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 48.54 | 20.36B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 48.34 | 20.28B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 54.3 | 18.54B | ||
| SRT.DE | SARTORIUS AG | 41.89 | 14.30B | ||
| QIA.DE | QIAGEN N.V. | 19.24 | 8.43B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 15.57 | 2.27B | ||
| EVT.DE | EVOTEC SE | N/A | 1.94B | ||
| GXI.DE | GERRESHEIMER AG | 7.47 | 952.61M | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.74 | 210.89M |
Related stock screener links
About ILU.DE
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Company Info
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA US
Employees: 9000
Phone: 18582024500
ILLUMINA INC / ILU.DE FAQ
What does ILLUMINA INC do?
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
What is the stock price of ILLUMINA INC today?
The current stock price of ILU.DE is 114.38 EUR. The price increased by 0.26% in the last trading session.
Does ILLUMINA INC pay dividends?
ILU.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of ILU stock?
ILU.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How many employees does ILLUMINA INC have?
ILLUMINA INC (ILU.DE) currently has 9000 employees.
What is ILLUMINA INC worth?
ILLUMINA INC (ILU.DE) has a market capitalization of 17.48B EUR. This makes ILU.DE a Large Cap stock.
ILU.DE Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ILU.DE. When comparing the yearly performance of all stocks, ILU.DE is one of the better performing stocks in the market, outperforming 78.67% of all stocks.
ILU.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE. While ILU.DE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
ILU.DE Financial Highlights
Over the last trailing twelve months ILU.DE reported a non-GAAP Earnings per Share(EPS) of 3.71. The EPS increased by 152.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.39% | ||
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| Debt/Equity | 0.42 |
ILU.DE Forecast & Estimates
28 analysts have analysed ILU.DE and the average price target is 107.33 EUR. This implies a price decrease of -6.16% is expected in the next year compared to the current price of 114.38.
For the next year, analysts expect an EPS growth of 96.03% and a revenue growth -0.86% for ILU.DE